China encourages pharmaceutical companies to timely pursue new GMP ...
News | 16 January 2013
In 2010, China's State Food and Drug Administration (?SFDA?) issued a new version of its Good Manufacturing Practice (the ?GMP?) regulations, which require manufacturers of sterile drugs (including blood products, vaccines, injections, etc.) to receive ...
Click on the link to read the full article at Lexology (registration)
(This link will open in a new window)
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
